Inhibition of Cell Growth in Culture by Quinones
- 1 June 1998
- journal article
- research article
- Published by Mary Ann Liebert Inc in Cancer Biotherapy & Radiopharmaceuticals
- Vol. 13 (3) , 185-188
- https://doi.org/10.1089/cbr.1998.13.185
Abstract
Quinones were studied for their growth inhibitory effect on cultured malignant cells. HCT-15 cells derived from human colon carcinoma were used for these experiments. Quinones used were arbutin in the benzoquinone group, juglone and lawsone in the naphthaquinone group, alizarin, emodin, 1,8-dihydroxyanthraquinone, and anthraquinone in the anthraquinone group, and xanthone. Cultured cells were incubated with various concentrations of the quinones for four days in a 5% C02 incubator, after which cell numbers were counted and significance of differences was analyzed by Student's t test. Anthraquinones and naphthaquinones used in these experiments were more effective than the monocyclic quinone. The 50% suppression dose was less than 12.5 μg/ml for them. The number of OH groups seemed to play an important role in the degree of the cell growth inhibition: anthraquinones with 2 or 3 OH groups were more effective than those with no OH group like, 9,10-dioxoanthracene and xanthone. In fact, anthraquinones with no OH group and xanthone were not significantly effective. Flow cytometric histograms revealed a specific pattern; that is, lawsone and juglone in the naphthaquinone group and alizarin and 1,8-dihydroxy-anthraquinone in the anthraquinone group blocked mainly the S phase, and emodin in the anthraquinone group blocked the G1 to S phase of the cell cycle.Keywords
This publication has 8 references indexed in Scilit:
- Tumor Cell Growth-Inhibiting Effect of Melanoidins Extracted from Miso and Soy SauceCancer Biotherapy & Radiopharmaceuticals, 1997
- Influence of Flavonoids on Cell Cycle Phase as Analyzed by Flow-CytometryCancer Biotherapy & Radiopharmaceuticals, 1997
- Suppression of Growth of Cultured Malignant Cells by Allomelanins, Plant-produced MelaninsCancer Biotherapy & Radiopharmaceuticals, 1997
- Influence of OH Group and Sugar Bonded to Flavonoids on Flavonoid-Mediated Suppression of Tumor Growth in vitroCancer Biotherapy & Radiopharmaceuticals, 1996
- Molecular modeling of singlet-oxygen binding to anthraquinones in relation to the peroxidating activity of antitumor anthraquinone drugs.Acta Biochimica Polonica, 1995
- Suppression of Tumor Cell Growth by Anthocyanins In VitroCancer Investigation, 1995
- Antimutagenic and anticarcinogenic effects of carotenoids and dietary palm oilNutrition and Cancer, 1992